3
|
Potemkina EG, Salomatina TA, Andreev EV, Abramov KB, Bannikova VD, Dengina NO, Nezdorovina VG, Zabrodskaya YM, Samochernykh KA, Odintsova GV. [MR morphometry in epileptology: progress and perspectives]. ZHURNAL VOPROSY NEIROKHIRURGII IMENI N. N. BURDENKO 2023; 87:113-119. [PMID: 37325834 DOI: 10.17116/neiro202387031113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Morphometric MRI analysis improves neuroimaging of structural changes in epilepsy. OBJECTIVE To investigate diagnostic potential of MR brain morphometry in neurosurgical epileptology. MATERIAL AND METHODS An interdisciplinary working group reviewed the studies devoted to MR morphometry in epileptology as a part of state assignment No. 056-00119-22-00. Study subject was trials of MR-morphometry in epilepsy. Searching for literature data was conducted in international and national databases between 2017 and 2022 using certain keywords. Final analysis included 36 publications. RESULTS Currently, MR brain morphometry allows measurement of cortical volume and thickness, surface area and depth of furrows, as well as analysis of cortical tortuosity and fractal changes. In neurosurgical epileptology, MR-morphometry has the greatest diagnostic value in MR-negative epilepsy. This method simplifies preoperative diagnosis and reduces costs. CONCLUSION Morphometry in neurosurgical epileptology is an additional method for verifying the epileptogenic zone. Automated programs simplify application of this method.
Collapse
Affiliation(s)
- E G Potemkina
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - T A Salomatina
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - E V Andreev
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - K B Abramov
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - V D Bannikova
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - N O Dengina
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - V G Nezdorovina
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - Yu M Zabrodskaya
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - K A Samochernykh
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| | - G V Odintsova
- Almazov National Medical Research Centre, Polenov Neurosurgery Research Institute, St. Petersburg, Russia
| |
Collapse
|
6
|
Zhang X, Chen W, Wu Y, Zeng W, Yuan Y, Cheng C, Yang X, Wang J, Yang X, Xu Y, Lei H, Cao X, Xu Y. Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry. Front Aging Neurosci 2021; 13:759934. [PMID: 34776935 PMCID: PMC8581620 DOI: 10.3389/fnagi.2021.759934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Accepted: 10/07/2021] [Indexed: 11/22/2022] Open
Abstract
Long-term therapy with levodopa (L-DOPA) in patients with Parkinson’s disease (PD) often triggers motor complications termed as L-DOPA-induced dyskinesia (LID). However, few studies have explored the pathogenesis of LID from the perspective of neuroanatomy. This study aimed to investigate macroscopic structural changes in a rat model of LID and the underlying histological mechanisms. First, we established the hemiparkinsonism rat model through stereotaxic injection of 6-hydroxydopamine (6-OHDA) into the right medial forebrain bundle, followed by administration of saline (PD) or L-DOPA to induce LID. Magnetic resonance imaging (MRI) and behavioral evaluations were performed at different time points. Histological analysis was conducted to assess the correlations between MRI signal changes and cellular contributors. Voxel-based morphometry (VBM) analysis revealed progressive bilateral volume reduction in the cortical and subcortical areas in PD rats compared with the sham rats. These changes were partially reversed by chronic L-DOPA administration; moreover, there was a significant volume increase mainly in the dorsolateral striatum, substantia nigra, and piriform cortex of the lesioned side compared with that of PD rats. At the striatal cellular level, glial fibrillary acidic protein-positive (GFAP+) astrocytes were significantly increased in the lesioned dorsolateral striatum of PD rats compared with the intact side and the sham group. Prolonged L-DOPA treatment further increased GFAP levels. Neither 6-OHDA damage nor L-DOPA treatment influenced the striatal expression of vascular endothelial growth factor (VEGF). Additionally, there was a considerable increase in synapse-associated proteins (SYP, PSD95, and SAP97) in the lesioned striatum of LID rats relative to the PD rats. Golgi-Cox staining analysis of the dendritic spine morphology revealed an increased density of dendritic spines after chronic L-DOPA treatment. Taken together, our findings suggest that striatal volume changes in LID rats involve astrocyte activation, enrichment of synaptic ultrastructure and signaling proteins in the ipsilateral striatum. Meanwhile, the data highlight the enormous potential of structural MRI, especially VBM analysis, in determining the morphological phenotype of rodent models of LID.
Collapse
Affiliation(s)
- Xiaoqian Zhang
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Wei Chen
- State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Innovation Academy for Precision Measurement Science and Technology, National Center for Magnetic Resonance in Wuhan, Chinese Academy of Sciences, Wuhan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Yi Wu
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Weiqi Zeng
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yuhao Yuan
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Chi Cheng
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Xiaoman Yang
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jialing Wang
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Xiaomei Yang
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yu Xu
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Hao Lei
- State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Innovation Academy for Precision Measurement Science and Technology, National Center for Magnetic Resonance in Wuhan, Chinese Academy of Sciences, Wuhan, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Xuebing Cao
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Yan Xu
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
7
|
Caldairou B, Foit NA, Mutti C, Fadaie F, Gill R, Lee HM, Demerath T, Urbach H, Schulze-Bonhage A, Bernasconi A, Bernasconi N. MRI-Based Machine Learning Prediction Framework to Lateralize Hippocampal Sclerosis in Patients With Temporal Lobe Epilepsy. Neurology 2021; 97:e1583-e1593. [PMID: 34475125 DOI: 10.1212/wnl.0000000000012699] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 07/30/2021] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND AND OBJECTIVES MRI fails to reveal hippocampal pathology in 30% to 50% of temporal lobe epilepsy (TLE) surgical candidates. To address this clinical challenge, we developed an automated MRI-based classifier that lateralizes the side of covert hippocampal pathology in TLE. METHODS We trained a surface-based linear discriminant classifier that uses T1-weighted (morphology) and T2-weighted and fluid-attenuated inversion recovery (FLAIR)/T1 (intensity) features. The classifier was trained on 60 patients with TLE (mean age 35.6 years, 58% female) with histologically verified hippocampal sclerosis (HS). Images were deemed to be MRI negative in 42% of cases on the basis of neuroradiologic reading (40% based on hippocampal volumetry). The predictive model automatically labeled patients as having left or right TLE. Lateralization accuracy was compared to electroclinical data, including side of surgery. Accuracy of the classifier was further assessed in 2 independent TLE cohorts with similar demographics and electroclinical characteristics (n = 57, 58% MRI negative). RESULTS The overall lateralization accuracy was 93% (95% confidence interval 92%-94%), regardless of HS visibility. In MRI-negative TLE, the combination of T2 and FLAIR/T1 intensities provided the highest accuracy in both the training (84%, area under the curve [AUC] 0.95 ± 0.02) and validation (cohort 1 90%, AUC 0.99; cohort 2 76%, AUC 0.94) cohorts. DISCUSSION This prediction model for TLE lateralization operates on readily available conventional MRI contrasts and offers gain in accuracy over visual radiologic assessment. The combined contribution of decreased T1- and increased T2-weighted intensities makes the synthetic FLAIR/T1 contrast particularly effective in MRI-negative HS, setting the basis for broad clinical translation. CLASSIFICATION OF EVIDENCE This study provides Class II evidence that in people with TLE and MRI-negative HS, an automated MRI-based classifier accurately determines the side of pathology.
Collapse
Affiliation(s)
- Benoit Caldairou
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Niels A Foit
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Carlotta Mutti
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Fatemeh Fadaie
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Ravnoor Gill
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Hyo Min Lee
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Theo Demerath
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Horst Urbach
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Andreas Schulze-Bonhage
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany
| | - Andrea Bernasconi
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany.
| | - Neda Bernasconi
- From the Neuroimaging of Epilepsy Laboratory (B.C., N.A.F., C.M., F.F., R.G., H.M.L., A.B., N.B.), McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Quebec, Canada; and Departments of Neurosurgery (N.A.F.) and Neuroradiology (T.D., H.U.), Freiburg Medical Center, and Department of Neurology (A.S.-B.), University of Freiburg, Germany.
| |
Collapse
|
8
|
Riederer F, Seiger R, Lanzenberger R, Pataraia E, Kasprian G, Michels L, Kollias S, Czech T, Hainfellner JA, Beiersdorf J, Baumgartner C. Automated volumetry of hippocampal subfields in temporal lobe epilepsy. Epilepsy Res 2021; 175:106692. [PMID: 34175792 DOI: 10.1016/j.eplepsyres.2021.106692] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 05/21/2021] [Accepted: 06/18/2021] [Indexed: 10/21/2022]
Abstract
INTRODUCTION Hippocampal sclerosis is the most frequent pathological substrate in drug resistant temporal lobe epilepsy (TLE). Recently 4 types of hippocampal sclerosis (HS) have been defined in a task force by the International League Against Epilepsy (ILAE), based on patterns of cell loss in specific hippocampal subfields. Type 1 HS is most frequent and has the most favorable outcome after epilepsy surgery. We hypothesized that volume loss in specific hippocampal subfields determined by automated volumetry of high resolution MRI would correspond to cell loss in histological reports. MATERIAL AND METHODS In a group of well characterized patients with drug resistant TLE (N = 26 patients, 14 with right-sided focus, 12 with left-sided focus) volumes of the right and left hippocampus and the hippocampal subfields CA1, CA2 + 3, CA4 and dentate gyrus (DG) were estimated automatically using FreeSurfer version 6.0 from high-resolution cerebral MRI and compared to a large group of healthy controls (N = 121). HS subtype classification was attempted based on histological reports. RESULTS Volumes of the whole hippocampus and all investigated hippocampal subfields (CA1, CA2 + 3, CA4 and DG) were significantly lower on the ipsilateral compared the contralateral side (p < 0.001) and compared to the healthy controls (p < 0.001). Conversely, whole hippocampal and hippocampal subfield volumes were not significantly different from healthy control values on the contralateral side. In 12 of 20 patients the pattern of hippocampal volume loss in specific subfields was in accordance with HS types from histology. The highest overlap between automated MRI and histology was achieved for type 1 HS (in 10 of 12 cases). CONCLUSION The automated volumetry of hippocampal subfields, based on high resolution MRI, may have the potential to predict the pattern of cell loss in hippocampal sclerosis before operation.
Collapse
Affiliation(s)
- Franz Riederer
- Department of Neurology, Clinic Hietzing & Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology, Vienna, Austria; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
| | - René Seiger
- Neuroimaging Labs, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
| | - Rupert Lanzenberger
- Neuroimaging Labs, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
| | | | - Gregor Kasprian
- Department of Radiology and Nuclear Medicine, Medical University of Vienna, Vienna, Austria
| | - Lars Michels
- Clinic of Neuroradiology, University Hospital Zurich, Zurich, Switzerland
| | - Spyros Kollias
- Clinic of Neuroradiology, University Hospital Zurich, Zurich, Switzerland
| | - Thomas Czech
- Department of Neurosurgery, Medical University of Vienna, Vienna, Austria
| | - Johannes A Hainfellner
- Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria
| | - Johannes Beiersdorf
- Department of Neurology, Clinic Hietzing & Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology, Vienna, Austria
| | - Christoph Baumgartner
- Department of Neurology, Clinic Hietzing & Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology, Vienna, Austria; Medical Faculty, Sigmund Freud Private University, Vienna, Austria
| |
Collapse
|